Abstract
The metabolic syndrome is recognized as a cluster of disturbances associated with obesity, type 2 diabetes and hypertension. Over the past two decades, the number of people with the metabolic syndrome has increased at an alarming rate. This increase is associated with the global epidemic of both obesity and diabetes. Cardiovascular mortality is increased among diabetics and obesity-related insulin-resistant patients, and obesity is currently recognized as independent risk factor for cardiovascular disease. We aimed to establish the effects of a short period of an altered diet on the heart using a rat model of hyperphagia-induced obesity (diet supplemented with sucrose and condensed milk for 8 weeks = DIO) compared to age-matched controls. Isolated, perfused hearts were subjected to global or regional ischaemia/reperfusion. Function on reperfusion was recorded and infarct size determined. A plasma lipid profile was established via HPLC-based methods and proteins involved in metabolic signalling determined either by western blotting or RT-PCR. 8 weeks of diet resulted in whole-body but not myocardial insulin resistance, increased plasma triglyceride and phospholipid levels as well as increased lipid peroxidation. Despite the similar baseline function, hearts from DIO animals showed significantly poorer postischaemic recovery than controls (41.9 % RPP recovery vs 57.9 %, P < 0.05, n = 7–11/group) but surprisingly, smaller infarct size (24.95 ± 1.97 vs 47.26 ± 4.05 % of the area at risk, P < 0.005, n = 8/group). Basal phosphorylation of PKB/Akt was elevated but IRS-1 and SERCA-2 expression severely downregulated. In conclusion, after only 8 weeks of a slight change in diet, the rat heart shows signs of metabolic remodelling. Some of these changes may be protective but others may be detrimental and eventually lead to maladaptation.
Similar content being viewed by others
References
Reaven GM (1988) The role of insulin resistance in human disease. Diabetes 37:1595–1602
Haffner SM (2000) Obesity and the metabolic syndrome: the San Antonio Heart Study. British J Nutr 83(Suppl 1):S67–S70
Grundy SM (2006) Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. J Am Coll Cardiol 47:1093–1100
Alexander CM, Landsman PB, Teusch SM, Haffner SM (2003) NCEP-defined metabolic syndrome, diabetes and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 52:1210–1213
Balkau B, Charles MA (1999) Comment on the provisional report from the WHO Consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 16:441–443
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High blood Cholesterol in Adults (2002) Third report of the NCEP—adult treatment panel III, final report. Circulation 106:3143–3421
Zimmet P, Alberti KG, Shaw J (2001) Global and societal implications of diabetes epidemic. Nature 414:782–787
Pyörälä K (1991) Hyperinsulinaemia as predictor of atherosclerotic vascular disease, epidemiological evidence. Diabetes Metab 17:87–92
Turner RC, Millns H, Neil HA, Stratton IM, Manley SE, Matthews DR, Holman RR (1998) Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective Diabetes Study (UKPDS:23). BMJ 316:823–828
Smith SC Jr (2007) Multiple risk factors for cardiovascular disease and diabetes mellitus. Am J Med 120:S3–S11
Rader DJ (2007) Effect of insulin resistance, dyslipidemia and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus. Am J Med 120:S12–S18
Hu FB, Stampfer MJ, Haffner SM, Soloman CG, Willett WC, Manson JF (2002) Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. Diabetes Care 25:1129–1134
Huisamen B, Pêrel SJC, Friedrich SO, Salie R, Strijdom H, Lochner A (2011) AngII receptor antagonism improves nitric oxide production, eNOS and PKB expression in hearts from a rat model of insulin resistance. Mol Cell Biochem 349:21–31
Du Toit EF, Smith W, Muller C, Strijdom H, Stouthammer B, Woodiwiss AJ, Norton GR, Lochner A (2008) Myocardial susceptibility to ischemic–reperfusion injury in a prediabetic model of dietary-induced obesity. Am J Physiol Heart Circ Physiol 294:H2343–H2366
Naderali EK, Pickavance LC, Wilding JPH, Williams G (2001) Diet-induced endothelial dysfunction in the rat is independent of the degree of increase in total body weight. Clin Sci 100:635–641
Huisamen B, Genis A, Lochner A (2011) Pre-treatment with a DPP-4 inhibitor is infarct sparing in hearts from obese, pre-diabetic rats. Cardiovasc Drugs Ther 25:13–20
Folch J, Lees M, Stanley GHS (1957) A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226:497–509
Esterbauer H, Striegl G, Puhl H, Rotheneder M (1989) Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 6:67–75
Pryor WA, Castle L (1984) Chemical methods for the detection of lipid hydroperoxides. Methods Enzymol 105:293–299
Jiang Z-Y, Woollard ACS, Wolff SP (1991) Lipid hydroperoxide measurement by oxidation of Fe2+ in the presence of xylenol orange. Comparison with the TBA Assay and an iodometric method. Lipids 26:853–856
Jiang Z-Y, Hunt JV, Wolff SP (2002) Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein. Anal Biochem 202:384–389
Markwell MA, Haas SM, Bieber LL, Tolbert NE (1979) A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 87:206–210
Lochner A, Genade S, Moolman JA (2003) Ischemic preconditioning: infarct size is a more reliable endpoint than functional recovery. Basic Res Cardiol 98:337–346
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Venter H, Genade S, Mouton R, Huisamen B, Harper IS, Lochner A (1991) Myocardial membrane cholesterol: effects of ischaemia. J Mol Cell Cardiol 23:1271–1286
Ritchie SA, Connell JMC (2007) The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis 17:319–326
Bergman RN, Kim SP, Hsu IR, Catalano KJ, Chiu JD, Kabir M, Richey JM, Ader M (2007) Abdominal obesity: role in the pathophysiology of metabolic disease and cardiovascular risk. Am J Med 120:S3–S8
Olefsky JM, Glass CK (2010) Macrophages, inflammation and insulin resistance. Ann Rev Physiol 72:219–246
Matthews DR, Hosaker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (2002) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetes Care 25:1891–1892
Cacho J, Sevillano J, De Castro J, Herrera E, Ramos MP (2008) Validation of simple indexes to assess insulin sensitivity during pregnancy in Wistar and Sprague-Dawley rats. Am J Physiol Endocrinol Metab 295:E1269–E1276
Park S-Y, Cho Y-R, Kim H-J et al (2005) Unraveling the temporal pattern of diet-induced insulin resistance in individual organs and cardiac dysfunction in C57BL/6 mice. Diabetes 54:3530–3540
Araki E, Lipes MA, Patti ME et al (1994) Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372:186–190
Matsiu T, Tao J, Del Monte F et al (2001) Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation 104:330–335
Jonassen AK, Sack MN, Mjøs OD, Yellon DM (2001) Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ Res 89:1191–1198
Young ME, McNulty P, Taegtmeyer H (2002) Adaptation and maladaptation of the heart in diabetes: part II: potential mechanisms. Circ 105:1861–1870
Russell RR III, Coven DL, Pypaert M et al (2004) AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. J Clin Invest 114:495–503
Stanley WC, Dabkowski ER, Fibeiro RF Jr, O’Connell KA (2012) Dietary fat and heart failure: moving from lipotoxicity to lipoprotection. Circ Res 110:764–776
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Huisamen, B., Dietrich, D., Bezuidenhout, N. et al. Early cardiovascular changes occurring in diet-induced, obese insulin-resistant rats. Mol Cell Biochem 368, 37–45 (2012). https://doi.org/10.1007/s11010-012-1340-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-012-1340-9